Type 1 neurofibromatosis complicated by pulmonary artery hypertension: a case report.

We describe the case of a patient with neurofibromatosis type 1 (NF1) complicated by severe pulmonary aterial hypertension (PAH); only seven cases have been reported on this association so far, and PAH seems to be related to the vascular involvement of neurofibromatosis. The histology of our patient's lung tissue showed thickening of arteries and veins by medial and/or intimal hypertrophy and fibrosis. In order to exclude a familiar PAH, the analysis of the bone morphogenetic protein receptor 2 gene was carried out, but no mutations were found. On the basis of histological findings and of the results of genetic study we believe that PAH was a complication of NF1 in our patient and we suggest to screen patients with NF1 for the presence of PAH by means of trans-thoracic echocardiogram.

[1]  C. Ricachinevsky,et al.  Treatment of pulmonary arterial hypertension. , 2006, Jornal de pediatria.

[2]  L. Messiaen,et al.  Neurofibromin binds to caveolin-1 and regulates ras, FAK, and Akt. , 2006, Biochemical and biophysical research communications.

[3]  D. Wilson,et al.  The BMP type II receptor is located in lipid rafts, including caveolae, of pulmonary endothelium in vivo and in vitro. , 2006, Vascular pharmacology.

[4]  I. Dokal,et al.  Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer , 2004, Expert Reviews in Molecular Medicine.

[5]  M. Hori,et al.  Novel insertional mutation in the bone morphogenetic protein receptor type II associated with sporadic primary pulmonary hypertension. , 2004, Circulation journal : official journal of the Japanese Circulation Society.

[6]  N. Rudarakanchana,et al.  Primary pulmonary hypertension: molecular basis and potential for therapy , 2004, Expert Reviews in Molecular Medicine.

[7]  D. Cooper,et al.  Evaluation of genotype-phenotype correlations in neurofibromatosis type 1 , 2003, Journal of medical genetics.

[8]  I. Campbell,et al.  Von Recklinghausen's neurofibromatosis: neurofibromatosis type 1 , 2003, The Lancet.

[9]  M. Kodama,et al.  von Recklinghausen disease complicated by pulmonary hypertension. , 2001, Chest.

[10]  J. Radcliffe,et al.  Neurofibromatosis: clinical presentations and anaesthetic implications. , 2001, British journal of anaesthesia.

[11]  S. Hodge,et al.  Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. , 2000, American journal of human genetics.

[12]  M. Kramer,et al.  Pulmonary hypertension secondary to neurofibromatosis: intimal fibrosis versus thromboembolism , 1999, Thorax.

[13]  D. Gutmann,et al.  Expression of the neurofibromatosis I gene product, neurofibromin, in blood vessel endothelial cells and smooth muscle , 1995, Neurobiology of Disease.

[14]  R. Pyeritz,et al.  Pulmonary hypertension and interstitial fibrosis in von Recklinghausen neurofibromatosis. , 1986, American journal of medical genetics.